Company

PharmAkea, Inc.

PharmAkea Therapeutics, Inc. develops small molecule therapeutics that target proteins linked to fibroproliferative diseases.

About

Founded in 2012 and based in San Diego, California, US, PharmAkea Therapeutics, Inc. develops small molecule therapeutics that target certain proteins linked to fibroproliferative diseases. Its recorded stage is Series A.

1Funding rounds

1Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in